Brief: Xspray Pharma Announces Results From Additional Bioequivalence Study

Xspray Pharma publ AB

14/01/2021 11:15

Jan 14 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * XSPRAY PHARMA ANNOUNCES RESULTS FROM ADDITIONAL BIOEQUIVALENCE STUDY AND PROVIDES UPDATE
REGARDING UPCOMING REGULATORY APPLICATIONS FOR ANDA AND 505(B)(2)
    * XSPRAY PHARMA AB (PUBL) - RESULTS ARE IN LINE WITH PREVIOUS BIOEQUIVALENCE STUDIES, BUT
RESULTS
SHOW THAT STUDY DESIGN IS ROBUST

Source text for Eikon:  ID:nMFN4jvD2R 
Further company coverage:  XSPRAY.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))